UnknownNot applicableNCT04560257

High Flow Nasal Cannula HFNC In Covid-19 Patients

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lahore General Hospital
Principal Investigator
Sardar Al-Fareed Zafar
Post-Graduate Medical Institute, Lahore General Hospital, Lahore Pakistan
Intervention
High flow nasal cannula HFNC(device)
Enrollment
30 target
Eligibility
18-80 years · All sexes
Timeline
20202020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04560257 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials